SCHEMBL21160072

SCHEMBL21160072

CNC(C)(C)NN(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KCNN4 O15554 1/20 0.38
LMNA P02545 2/20 0.38
CYP2D6 P10635 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 4/20 0.35
NPSR1 Q6W5P4 3/20 0.35
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTT P42858 2/20 0.32
TSHR P16473 1/20 0.32
GAA P10253 3/20 0.32
MAPT P10636 2/20 0.32
ALOX12 P18054 1/20 0.32
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9699580 0.71 KMT2A (0.52) KMT2AMEN1SMN1; SMN2KCNN4LMNA
SCHEMBL27691374 0.70 KMT2A (0.38) KMT2AMEN1SMN1; SMN2LMNACYP2D6
Methyl Alcohol SCHEMBL28587291 0.70 KMT2A (0.42) KMT2AMEN1SMN1; SMN2LMNAL3MBTL1
Alcohol SCHEMBL28593573 0.65 ALDH1A1 (0.43) KMT2AMEN1SMN1; SMN2ALDH1A1NPSR1
SCHEMBL31413696 0.65 KMT2A (0.44) KMT2AMEN1SMN1; SMN2LMNACYP2D6
SCHEMBL609177 0.61 L3MBTL1 (0.43) KMT2AMEN1SMN1; SMN2KCNN4LMNA
Benzene SCHEMBL22658153 0.61 ALDH1A1 (0.56) KMT2AMEN1SMN1; SMN2LMNAL3MBTL1
SCHEMBL2056786 0.61 MEN1 (0.40) KMT2AMEN1SMN1; SMN2KCNN4LMNA
SCHEMBL45354 0.61 MEN1 (0.40) KMT2AMEN1SMN1; SMN2KCNN4LMNA
SCHEMBL7646197 0.61 KMT2A (0.41) KMT2AMEN1SMN1; SMN2LMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759749-B2 Therapeutic agent for diabetes JCR PHARMACEUTICALS CO., LTD. (JP) 2020-09-01 US disclosed
US-20190202781-A1 NOVEL THERAPEUTIC AGENT FOR DIABETES JCR PHARMACEUTICALS CO., LTD. (JP) 2019-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190202781-A1 NOVEL THERAPEUTIC AGENT FOR DIABETES GPR119, IAPP, DPP4 KMT2A 3897/4885MEN1 4253/4885SMN1; SMN2 3948/4885
US-10759749-B2 Therapeutic agent for diabetes GPR119, IAPP, DPP4 KMT2A 3159/4885MEN1 3662/4885SMN1; SMN2 3104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.